This was a population-based observational study to assess the impact of managed care (MC) on several dimensions of quality of surgical care among Medicare beneficiaries undergoing carotid endarterectomies (CEAs) (N = 9308) in New York. Clinical data were abstracted from medical charts to assess appropriateness and deaths or strokes within 30 days of surgery. Differences in patients, appropriateness, and outcomes were compared using chi-square tests; risk-adjusted outcomes were compared using regression. Fee-For-Service (FFS, N = 8691) and MC (N = 897) CEA patients had similar indications for surgery, perioperative risk, and comorbidities. There were no differences in inappropriateness between FFS and MC (8.6% vs 8.4%). MC patients were less likely to use a high-volume surgeon (20.1% vs 13.5%) or hospital (20.5% vs 13.0%, P < .05). There were no differences in risk-adjusted rates of death or stroke (OR = 0.97; 95% CI = 0.69-1.37). Medicare MC plans did not have a positive impact on inappropriateness, referral patterns, or outcomes of CEA. (Am J Med Qual 2008;23:448-456)
Managed care (MC) spread throughout the health industry in the 1980s and became the dominant form of health insurance in the 1990s. 1 Advocates claimed that the new arrangements created by these organizations would reduce or at least control health care costs while improving the quality of health care. 2, 3 The latter objective would be achieved by a variety of specific interventions, including precertification of elective procedures to assure their appropriateness and selective referral of patients to high-quality doctors and hospitals. Managed care plans have both financial and quality of care incentives to prevent overuse of procedures and poor surgical outcomes. We sought to assess whether MC affected any of several dimensions of health care quality by examining its impact on the use of carotid endarterectomy (CEA) among Medicare beneficiaries in New York State in the late 1990s.
Carotid endarterectomy, surgery to prevent stroke, is an ideal procedure with which to investigate this question for several reasons. It is a common and costly inpatient procedure with significant risks of immediate complications. By the end of the 1990s, a large body of data was available from published randomized controlled trials (RCTs) [4] [5] [6] [7] [8] [9] and national guidelines that established the circumstances under which the procedure produced benefits for patients. 10, 11 Because the procedure is nearly always performed electively, MC plans had the opportunity to employ several of their readily available programs (including preauthorization) to influence the appropriateness of patients selected for the procedure, as well as selective referral to (or contract with) high-quality surgeons or hospitals. Because approximately three quarters of CEAs are performed among patients 65 years of age or older, the Medicare population provides an ideal group in which to examine this procedure.
This study sought to determine whether Medicare patients enrolled in Medicare Choice MC plans (the precursor of Medicare's current MC plans) had: (1) lower rates of inappropriate CEAs, (2) operations performed more frequently by highvolume surgeons or hospitals, or (3) better perioperative outcomes compared with patients enrolled in fee-for-service (FFS) Medicare.
METHODS

Study Population
The New York Carotid Artery Surgery (NYCAS) study examined all Medicare beneficiaries who underwent CEA (ICD-9 CM 38.12) between January 1, 1998 and June 30, 1999 in New York State. Details of the NYCAS study have been described previously. 12 We used Medicare Part A claims to identify patients with traditional FFS Medicare coverage (N = 9761). Because beneficiaries enrolled in MC plans do not have Part A claims, we employed the following strategy to find these MC cases. First, we identified 1844 CEAs done in New York on patients aged ≥65 years using the New York state hospital discharge database that did not have Part A claims. Second, using the Medicare eligibility files, we excluded those who were not known Medicare enrollees (199) . Managed care was defined as any Medicare Choice approved MC plan including HMO/staff, group, network, independent physician association, or mixed models. We searched the Medicare enrollment file to determine a patient's insurance coverage (FFS vs MC) for the month of surgery, or the prior month if the surgery occurred within the first 10 days of the month (to allow for a lag in updating the enrollment files). This yielded a total of 11 406 potentially eligible FFS and MC cases. Copies of the inpatient medical records were requested by the Medicare quality improvement organization in New York referred to as the Island Peer Review Organization (IPRO). The study was approved by the Mount Sinai Institutional Review Board.
Island Peer Review Organization successfully obtained the medical charts of 10 817 potentially eligible cases (94.8%). Among these, 628 were excluded for same-side reoperations (308), surgery combined with a major procedure other than coronary artery bypass graft (CABG; 210), or no CEA was performed (110). For the analyses presented here, an additional 601 cases were excluded because critical clinical information necessary to make an appropriateness assessment was missing from the medical charts (551) or the case represented a scenario not rated by the consensus panel (50). Among these excluded cases 18.0% had MC and 82.0% had FFS insurance. Therefore, the NYCAS study contains complete information on 9588 CEAs among Medicare beneficiaries: 8691 patients with FFS coverage and 897 patients with MC coverage.
Data Collection and Measurement
Detailed clinical information was abstracted from hospital charts by trained nurse abstractors including: sociodemographics; neurological, medical, and surgical history; admission neurological exam, functional status, laboratory values, medications, and diagnostic imaging test results. Reasons for surgery were grouped into symptomatic and asymptomatic indications. Symptomatic indications included any of the following within 12 months of CEA: carotid Transient Ischemic Attack (TIA), amaurosis fugax, crescendo TIA, or strokes (major, minor, or in evolution). Patients who did not have any symptoms referable to a carotid artery stenosis within 12 months prior to surgery were considered asymptomatic (including those with vertebrobasilar TIAs). Comorbidity was defined as high (end-stage disease, severe disability, 13 or ≥3 Revised Cardiac Risk Index risk factors 14 ), moderate (2 cardiac risk factors), or low (≤1 risk factor). 14, 15 Surgical specialty was determined from the American Medical Association and state licensing board databases. Hospital teaching status and location (metropolitan statistical area size) were obtained from the American Hospital Association. Abstractors needed to pass a series of quality assurance and inter-rater reliability tests. Assessing the impact of insurance on quality of CEA care was a substudy that emerged late in the project, so abstractors were blinded to this as a potential study hypothesis at the time of abstraction. All of the data elements reported on had substantial to near-perfect agreement (Kappas from 0.60 to 1.0).
Appropriateness Ratings
We used the CEA appropriateness ratings that we have described previously. 15 These ratings were generated using the RAND appropriateness method from 1998, for which a national panel of 9 experts from the fields of vascular surgery, neurosurgery, neurology, internal medicine, radiology, and vascular medicine, reviewed, rated, discussed, and re-rated 1557 mutually exclusive indications for surgery-a validated process used previously. [15] [16] [17] [18] The results of all of the main North American trials were known at the time the expert panel deliberated. Carotid endarterectomy was considered appropriate when the benefits exceeded the risks, uncertain when the benefits equaled the risks, and inappropriate when the risks outweighed the benefits. Each expert rated each indication on a 9point scale (1-3 = inappropriate, 4-6 = uncertain, and 7-9 = appropriate). An indication was considered inappropriate if the median panel rating was between 1 and 3 and there was no disagreement. [15] [16] [17] [18] Disagreement was present when 3 or more panel members rated an indication as inappropriate (1-3) and 3 or more rated it as appropriate (7) (8) (9) .
Outcomes
Information about perioperative deaths, strokes, and TIAs was abstracted from the inpatient medical record of the index admission and all readmissions within 30 days of surgery. Experienced research nurses abstracted data on complications from a review of admission notes, daily hospital notes, discharge summaries, and reports of brain imaging tests. Two study physicians (including 1 neurologist) independently reviewed the records of all patients identified as having stroke or TIA complications. Initial agreement was 95%, and disagreements were resolved by consensus or a third reviewer, if necessary.
Analysis Plan
Differences in patient, surgeon, and hospital characteristics, rates of inappropriateness, and outcomes of MC versus FFS patients were compared using chi-square tests, student t tests, and Wilcoxon rank-sum tests, as appropriate. To examine whether MC patients were more likely to be referred to highvolume surgeons or hospitals, we used chi-square tests comparing quintiles of surgeon and hospital volume. Similar results were obtained when modeling volume by tertiles and quartiles.
We used multiple logistic regression with generalized estimating equations (to account for clustering) to investigate differences in risk-adjusted rates of combined death or nonfatal stroke between FFS and MC patients. Two risk-adjustment approaches were used. Model 1 assessed the independent impact of insurance type after controlling for prognostic factors from a previously validated CEA-specific risk model (including symptom status, active coronary artery disease, contralateral stenosis, type of anesthesia, and arteriotomy repair). 21 Model 2 controlled for the covariates that were not balanced between the 2 insurance groups (ie, age, race, past stroke, hypertension, chronic obstructive pulmonary disease, diabetes, surgeon volume, surgeon years since graduation, hospital volume, and metropolitan statistical area size). Surgeon volume was highly collinear with board specialty (and more closely related to outcomes), so specialty was not included in Model 2. An alternate model that included surgical specialty (instead of surgeon volume) produced similar results. All analyses consider 2-sided p values of .05 as statistically significant and were performed using SAS 9.0 (SAS Institute, Inc, Cary, North Carolina).
RESULTS
Patient Characteristics and Clinical Indications for CEA
The sociodemographic and clinical characteristics of the combined 9588 FFS and MC cases are shown in Table 1 . There were no significant differences in patient characteristics with respect to sex, comorbidity scores, cerebrovascular disease, heart disease, diabetes, kidney disease, or degree of disability among patients with FFS compared to MC insurance. FFS patients were one half year older on average (74.6 vs 74.1 years, P = .02). There were also more FFS patients at the extremes of age (<65 or ≥ 85 years), in part, because patients <65 years old with end-stage kidney disease or disability are covered by FFS Medicare. There were more nonwhites in the MC group (9.6% vs 6.8%, P < .001). There were also small, but significantly higher rates of hypertension and chronic obstructive pulmonary disease among FFS cases. As shown in Table 2 , the clinical indications for CEA and severity of carotid disease (ipsi-and contralateral stenosis, disability score) were similar in the 2 groups.
Appropriateness of CEA Figure 1 shows that there were no differences in rates of inappropriate surgery between FFS and MC cases (8.6% vs 8.4%, P = .55). Nor were there any differences in inappropriateness when stratifying by clinical indication for surgery (asymptomatic vs symptomatic) or surgical specialty. The reasons for inappropriate CEA between FFS and MC were also the same (data not shown).
Surgeon Referral Patterns
The 9588 cases were performed by 488 surgeons divided among the following specialties: general surgery (45.4%), vascular (26.8%), cardiothoracic (11.5%), neurosurgery (7.6%), and missing (8.8%). Just over half of cases (52.7%) were performed by vascular surgeons, 33.6% by general surgeons, 6.9% by cardiothoracic surgeons, and 5.4% by neurosurgeons ( Table 3 ). The median annualized number of cases per surgeon was 31 (interquartile range, 14-54). Overall, FFS patients were operated on by surgeons with higher annual Medicare volume compared to their MC counterparts (mean 52.7 vs 38.9 cases/surgeon, P < .0001), largely because of fewer MC patients being operated on by surgeons in the top 2 volume quintiles (Table 3) . There were no significant differences in fee-for-service vs. Managed care patients were more likely to be operated on by surgeons at the extremes of experience (≤ 10 years from graduation from medical school) or ≥ 41 years from graduation, P < .0001). The likelihood of being operated on by a vascular or general surgeon, the 2 most common types of surgeons performing CEA, was similar across insurance groups. Managed care patients had modestly fewer cases performed by neurosurgeons and more by cardiothoracic surgeons, though these 2 specialties accounted for only 12.2% of cases.
Hospital Referral Patterns
Carotid endarterectomy was performed in 166 hospitals; 39.1% were teaching hospitals. Median hospital volume was 74 cases per year (IQR, 41-161).
Fee-for-service patients were more likely to be operated on in higher volume hospitals (109.9 vs 89.8 cases/year, P < .0001), mostly because of fewer MC cases being done at the highest quintile facilities ( Table 3 ). There were no differences in the percentage of cases performed at teaching hospitals. Although two thirds of cases overall (66.2%) were performed in large cities (≥1 million residents), a larger proportion of MC cases were performed in hospitals in these large cities (87.9%) versus FFS (64.0%, P < .0001).
Perioperative Outcomes
There were no differences in unadjusted rates of the combined end point of perioperative death or nonfatal stroke between FFS and MC cases (4.2% P values indicate that extent to which there were statistically significant differences between fee-for-service and managed care patients on a given variable (eg, surgeon or hospital characteristics). CEA = carotid endarterectomy. vs 4.4%, P = .81). Rates of death, nonfatal stroke, and myocardial infarction also were similar ( Figure 2 ). Nor were there differences in risk-adjusted rates of death or stroke between FFS and MC patients (Model 1, OR = 0.97, 95 CI = 0.69-1.37; Model 2, OR = 0.93, CI = 0.65-1.31). Model 2 included adjustment for metropolitan statistical area (MSA) size. Secondary analyses that further adjusted Model 1 (based on a validated CEA-specific risk model) for MSA size produced similar results.
DISCUSSION
We used detailed clinical data from a statewide, population-based cohort study of 9588 Medicare beneficiaries who underwent CEA (a common, elective, vascular surgical procedure) performed in 166 hospitals by 488 surgeons to examine several potential differences in the appropriateness, referral patterns, and outcomes of surgical care between patients with FFS versus MC insurance. Though rates of inappropriate surgery were low in both groups, we found no differences in inappropriateness between the 2 groups overall. This result was consistent across clinical indications for CEA and by surgical specialty.
Overuse of CEA is a good potential tracer for evaluating the effectiveness with which MC might influence health care quality for several reasons. It is an expensive, potentially risky, elective procedure that usually requires prior authorization. High rates of inappropriate CEA were also reported by several prominent studies. 17, 22 The evidence base for determining who benefits from CEA is very strong, with several large international RCTs directly addressing this issue. [4] [5] [6] [7] [8] [9] In addition, national subspecialty guidelines outlining appropriate candidates for CEA were widely available and highly publicized. 10, 11 In an earlier analysis of the NYCAS dataset, we found that following the publication of the RCTs, rates of inappropriate CEA dropped from 32% to 8%, suggesting that referring physicians and surgeons were heavily influenced by these data. 12 Health plans had access to the same data and guidelines as these physicians, as well as several commercial products for rating appropriateness. We infer from the fact that there was no difference in rates of inappropriate surgery between FFS and MC plans that there was no effective case-level assessment of appropriateness by MC plans. However, the current study cannot determine if MC plans tried to influence patient selection but failed, or never tried at all.
MC patients were less likely to have their procedure performed by a high-volume surgeon or hospital. The reasons for this finding are unknown. Managed care plans could have excluded high-volume providers from their networks (or required higher co-payments to use them). Conversely, some high-volume providers may have declined MC contracts. This appears unlikely as the highest volume hospitals and surgeons still had a significant proportion of MC cases. Although the study period precedes the work of the Leapfrog Group and other advocates of volume-oriented selective referral patterns, 23, 24 the favorable association between provider volume and outcomes had been known for several years prior to the study period. 25 Plans could have had access to provider volume from the New York State hospital discharge database if they were interested. It is also worth noting that there is no certificate of need policy in New York that limited the number of hospitals or surgeons who perform CEA, which partly explains the wide variation in caseload we found.
The lack of difference in rates of perioperative death or stroke between the 2 insurance groups could be explained by the fact that there were no direct mechanisms that would have given MC plans provider-specific outcome data. Although New York has been a national leader in promoting efforts to measure and publicly report hospitaland surgeon-specific complication rates for cardiovascular procedures like CABG and coronary angioplasty, there was no such systematic reporting of CEA outcomes during this period.
The literature examining the impact of MC is vast and mixed. Systematic reviews have concluded that there are no consistent differences in quality of care. 26 Although many studies have focused on differences in health care utilization rates, only a few have rigorously examined differences in appropriate use of care, 26 and these have largely examined underuse of indicated care. Gaudagnoli et al found that indicated coronary angiography was underused for Medicare patients after myocardial infarction with MC insurance (compared to FFS) but there were no differences in inappropriateness. 27 No prior studies have reported differences in risk-adjusted rates of surgical complications by insurance type.
Other investigators have reported a lack of alignment between theoretical health plan financial and quality incentives and actual plan behavior. Rates of CEA and other high-cost cardiac procedures were higher in for-profit health plans (compared to nonprofit ones) suggesting that health plans were not restricting care. 28 Medicare and privately insured patients in MC plans in New York were less likely to undergo CABG surgery at a low-mortality hospital despite the public reporting of CABG outcomes data. 29 Several potential limitations are worth noting. First, you may not be able to generalize our results to other states or patient populations. However, New York state accounts for 14% of the Medicare population, 29 and 8% of all CEAs performed nationwide 31,32 ; three quarters of CEAs are performed on Medicare beneficiaries. 14 Second, the degree of MC competition during the study period in New York would be considered moderate. During this period the MC penetration in New York was similar to that of the average state in the United States during the period. Third, there may have been some misclassification of insurance, though insurance status was based on both hospital insurance data and the Medicare eligibility files and any misclassification should be randomly distributed. Fourth, though the expert judgments that generated the appropriateness ratings are subjective, the internal consistency, reliability, and validity of this methodology for procedures with a strong evidence base of RCTs is very good. 18, [33] [34] [35] Fifth, the NYCAS study only contains data on patients who had surgery, so we cannot comment on any influence of insurance on patients who were potentially eligible for CEA but did not have it. We also did not know patients' zip codes and so could not directly calculate proximity to a high-volume provider. However, we controlled for the MSA size of the index hospital as a surrogate measure of access to a high-volume provider. The vast majority of MC patients (87.9%) were operated on in cities of 1 million residents or more, compared to FFS (64.0%), making lack of access to a high-volume or low-complication rate provider an unlikely explanation. Lastly, these data reflect practice in 1998 and the first half of 1999. The underlying evidence base of RCTs of CEA and national practice guidelines recommending their use have been stable over time. 10, 11, 19, 20, 36 In summary, while MC plans had the time, opportunity, evidence based guidelines, and financial and quality incentives to rationalize the use of CEA, they did not have a positive impact on inappropriateness, referral to high-volume providers, or clinical outcomes. Whether these findings reflect the fact that MC plans tried to exert such influence but failed or did not try at all is a worthy subject for future research.
